Biotech Pharmaceutical Co., Ltd.

Biotech Pharmaceutical Co., Ltd. was established in 2000 as a specialized biotechnology firm focused on the research, development, and production of monoclonal antibodies and therapeutic vaccines. Operating within the chemicals and manufacturing sectors, the company addresses malignant tumor treatments through advanced biotechnological processes. Its strategic foundation in the Beijing Economic and Technological Development Area facilitates high-level scientific research and industrial-scale production capabilities.

The company maintains a robust operational footprint with 500-1,000 employees dedicated to maintaining world-class antibody research standards. By integrating an antibody industrialization base, Biotech Pharmaceutical Co., Ltd. has established one of the most advanced facilities in China for large-scale therapeutic vaccine manufacturing. This infrastructure supports a comprehensive R&D pipeline, ensuring that production systems meet rigorous international benchmarks for pharmaceutical quality and technological innovation.

With over two decades of experience, the firm continues to advance its position in the global biotechnology market. The organization emphasizes continuous technological innovation to refine its therapeutic offerings and expand its clinical impact. Meet Biotech Pharmaceutical Co., Ltd.'s team to learn more about the leadership and scientific experts driving these advancements. The company remains committed to its mission of delivering high-quality medical solutions through its specialized production base in Beijing, leveraging its unique investment background to sustain long-term growth and development in the oncology treatment sector.